# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and raises the price target from $100 to $103.
Mizuho analyst John Roberts maintains Cabot (NYSE:CBT) with a Buy and raises the price target from $104 to $109.
Cabot (NYSE:CBT) reported quarterly earnings of $1.78 per share which beat the analyst consensus estimate of $1.66 by 7.23 perc...
Deutsche Bank analyst David Begleiter downgrades Cabot (NYSE:CBT) from Buy to Hold and raises the price target from $88 to $95.
Grant will support development of innovative, scalable manufacturing processes for producing carbon catalyst supports for fuel ...
Mizuho analyst John Roberts initiates coverage on Cabot (NYSE:CBT) with a Buy rating and announces Price Target of $104.